A fresh analysis of data on the immune response generated by the bivalent COVID-19 booster showed strong results against the newer omicron sublineages, Pfizer and German partner BioNTech said Friday. Read more
Tag: Pfizer
Pfizer stock climbs on Q3 top and bottom line beat, raised outlook
Pfizer Inc.’s PFE, -1.86% stock rose 3.4% before market open on Tuesday, lifted by the pharmaceutical giant’s third-quarter earnings. The company earned $1.51 a share on net income of $8.608 Read more
Pfizer sets new prices for its COVID-19 vaccines. The cost? $110 to $130 per dose
Pfizer Inc. PFE, +3.06% said Thursday that it plans to sell the COVID-19 shot it developed with BioNTech SE BNTX, +4.59% for $110 to $130 per dose once the U.S. Read more
Pfizer sets new prices for its COVID-19 vaccines. The cost? $110 to $130 per dose
Pfizer Inc. PFE, +4.67% said Thursday that it plans to sell the COVID-19 shot it developed with BioNTech SE BNTX, +7.02% for $110 to $130 per dose once the U.S. Read more
Pfizer and BioNTech report positive data in trial of omicron-targeting bivalent booster in individuals aged 18 and older
Pfizer Inc. PFE, +0.26% and German partner BioNTech SE BNTX, +5.53% said Thursday early data from a Phase 2/3 clinical trial of their omicron BA.4/BA.5-adapated bivalent booster showed positive results Read more
Pfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11
Pfizer and German partner BioNTech said Monday they’re seeking Food and Drug Administration authorization for their omicron-targeting bivalent vaccine for use in children 5 to 11 years of age. The Read more
Pfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11
Pfizer and German partner BioNTech said Monday they’re seeking Food and Drug Administration authorization for their omicron-targeting bivalent vaccine for use in children 5 to 11 years of age. The Read more
Vaccine stocks Pfizer, BioNTech, Moderna and Novavax slide after Biden says pandemic is over
Stocks of the three key vaccine makers fell sharply Monday, after President Joe Biden said the pandemic is over, in an interview with “60 Minutes” that aired on Sunday. Moderna Read more
Report finds Americans with long COVID losing billions in wages, as Moderna sues Pfizer and BioNTech over mRNA patents
Some 16 million Americans of working age have long-term COVID and as many as 4 million are not working as they struggle with their symptoms, according to a new report from Read more
Moderna sues Pfizer and BioNTech for patent infringement relating to the mRNA platform used to develop COVID vaccines
Moderna Inc. MRNA, -1.49% said Friday it is suing Pfizer Inc. PFE, -1.06% and German partner BioNTech SE BNTX, -2.27% for infringing patents relating to its mRNA platform, the source Read more
- 1
- 2